Aurinia Pharmaceuticals AUPH Stock
Aurinia Pharmaceuticals Price Chart
Aurinia Pharmaceuticals AUPH Financial and Trading Overview
Aurinia Pharmaceuticals stock price | 5.09 USD |
Previous Close | 9.86 USD |
Open | 9.85 USD |
Bid | 0 USD x 800 |
Ask | 0 USD x 2200 |
Day's Range | 9.63 - 10 USD |
52 Week Range | 4.07 - 12.6 USD |
Volume | 1.11M USD |
Avg. Volume | 2.84M USD |
Market Cap | 1.42B USD |
Beta (5Y Monthly) | 1.182746 |
PE Ratio (TTM) | N/A |
EPS (TTM) | -0.54 USD |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | N/A |
1y Target Est | 16 USD |
AUPH Valuation Measures
Enterprise Value | 1.07B USD |
Trailing P/E | N/A |
Forward P/E | -23.642859 |
PEG Ratio (5 yr expected) | N/A |
Price/Sales (ttm) | 9.674335 |
Price/Book (mrq) | 3.6373627 |
Enterprise Value/Revenue | 7.29 |
Enterprise Value/EBITDA | -10.646 |
Trading Information
Aurinia Pharmaceuticals Stock Price History
Beta (5Y Monthly) | 1.182746 |
52-Week Change | -6.58% |
S&P500 52-Week Change | 20.43% |
52 Week High | 12.6 USD |
52 Week Low | 4.07 USD |
50-Day Moving Average | 10.59 USD |
200-Day Moving Average | 8.15 USD |
AUPH Share Statistics
Avg. Volume (3 month) | 2.84M USD |
Avg. Daily Volume (10-Days) | 1.7M USD |
Shares Outstanding | 143.03M |
Float | 140.04M |
Short Ratio | 5.83 |
% Held by Insiders | 7.07% |
% Held by Institutions | 38.23% |
Shares Short | 16.7M |
Short % of Float | 11.72% |
Short % of Shares Outstanding | 11.67% |
Dividends & Splits
Trailing Annual Dividend Rate | 0 |
Trailing Annual Dividend Yield | 0% |
5 Year Average Dividend Yield | N/A |
Payout Ratio | 0 |
Last Split Factor |
Financial Highlights
Fiscal Year
Fiscal Year Ends | December 31, 2022 |
Most Recent Quarter (mrq) | March 31, 2023 |
Next Fiscal Year End | December 31, 2023 |
Profitability
Profit Margin | -65.90% |
Operating Margin (ttm) | -70.27% |
Gross Margin | 65.01% |
EBITDA Margin | -68.47% |
Management Effectiveness
Return on Assets (ttm) | -13.45% |
Return on Equity (ttm) | -23.077% |
Income Statement
Revenue (ttm) | 146.81M USD |
Revenue Per Share (ttm) | 1.03 USD |
Quarterly Revenue Growth (yoy) | 59.09% |
Gross Profit (ttm) | 83.38M USD |
EBITDA | -100530000 USD |
Net Income Avi to Common (ttm) | -96756000 USD |
Diluted EPS (ttm) | -0.66 |
Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
Total Cash (mrq) | 360.86M USD |
Total Cash Per Share (mrq) | 2.52 USD |
Total Debt (mrq) | 7.93M USD |
Total Debt/Equity (mrq) | 2.03 USD |
Current Ratio (mrq) | 10.076 |
Book Value Per Share (mrq) | 2.73 |
Cash Flow Statement
Operating Cash Flow (ttm) | -64453000 USD |
Levered Free Cash Flow (ttm) | -22619500 USD |
Profile of Aurinia Pharmaceuticals
Country | United States |
State | BC |
City | Victoria |
Address | 4464 Markham Street |
ZIP | V8Z 7X8 |
Phone | 250 708 4272 |
Website | https://www.auriniapharma.com |
Industry | Biotechnology |
Sector(s) | Healthcare |
Full Time Employees | 300 |
Aurinia Pharmaceuticals Inc., a commercial-stage biopharmaceutical company, focuses on developing and commercializing therapies to treat various diseases with unmet medical need in the United States. The company also offers LUPKYNIS for the treatment of adult patients with active lupus nephritis. It has a collaboration and license agreement with Otsuka Pharmaceutical Co., Ltd. Aurinia Pharmaceuticals Inc. is headquartered in Victoria, Canada.
Q&A For Aurinia Pharmaceuticals Stock
What is a current AUPH stock price?
Aurinia Pharmaceuticals AUPH stock price today per share is 5.09 USD.
How to purchase Aurinia Pharmaceuticals stock?
You can buy AUPH shares on the NasdaqGM exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Aurinia Pharmaceuticals?
The stock symbol or ticker of Aurinia Pharmaceuticals is AUPH.
Which industry does the Aurinia Pharmaceuticals company belong to?
The Aurinia Pharmaceuticals industry is Biotechnology.
How many shares does Aurinia Pharmaceuticals have in circulation?
The max supply of Aurinia Pharmaceuticals shares is 144.62M.
What is Aurinia Pharmaceuticals Price to Earnings Ratio (PE Ratio)?
Aurinia Pharmaceuticals PE Ratio is now.
What was Aurinia Pharmaceuticals earnings per share over the trailing 12 months (TTM)?
Aurinia Pharmaceuticals EPS is -0.54 USD over the trailing 12 months.
Which sector does the Aurinia Pharmaceuticals company belong to?
The Aurinia Pharmaceuticals sector is Healthcare.
Aurinia Pharmaceuticals AUPH included in indexes
Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume |
---|
Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume | |
---|---|---|---|---|---|---|---|
{{ item.name }} {{ item.symbol }} | {{ item.price }} {{ item.price_usd }} |
{{ item.change_pct }}
|
{{ item.volume }} {{ item.volume_usd }} | {{ item.low }} {{ item.low_usd }} | {{ item.high }} {{ item.high_usd }} | {{ item.components_count }} - | {{ item.volume }} {{ item.volume_usd }} |
NASDAQ Composite IXIC | 16103.45 USD — |
+0.82
|
4.52B USD — | 16094.17 USD — | 16247.59 USD — | — - | 4.52B USD — |
NASDAQ Composite Total Return I XCMP | 19565.06 USD — |
+0.82
|
— — | 19553.78 USD — | 19740.18 USD — | — - | — — |
NASDAQ Developed ex US SC NTR G NQDMXUSSCGBPN | 1704.47 GBP 2179.91 USD |
0
|
— — | 1704.47 GBP 2179.91 USD | 1704.47 GBP 2179.91 USD | — - | — — |
NASDAQ Biotechnology NBI | 4337.34 USD — |
-0.65
|
— — | 4335.84 USD — | 4376.86 USD — | — - | — — |
NASDAQ HealthCare IXHC | 986.88 USD — |
-0.25
|
— — | 986.44 USD — | 994.67 USD — | — - | — — |
NASDAQ Global Market Composite NQGM | 2185.85 USD — |
-0.31
|
— — | 2177.48 USD — | 2204.21 USD — | — - | — — |
Stlmt ID NASDAQ Biotechnology NBX | 4604.4 USD — |
-2.98
|
— — | 4555.41 USD — | 4917.8 USD — | — - | — — |
- {{ link.label }} {{link}}